Brevan Howard Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,137
Closed -$221K 1266
2024
Q4
$221K Buy
+4,137
New +$221K ﹤0.01% 846